Panitumumab in Japanese Patients with Unresectable Colorectal Cancer: A Post-marketing Surveillance Study of 3085 Patients†-Reference-Cited by-同舟云学术

Panitumumab in Japanese Patients with Unresectable Colorectal Cancer: A Post-marketing Surveillance Study of 3085 Patients†

Published:2014-02-12 Issue:3 Volume:44 Page:214-223
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Boku Narikazu,Sugihara Kenichi,Kitagawa Yuko,Hatake Kiyohiko,Gemma Akihiko,Yamazaki Naoya,Muro Kei,Hamaguchi Tetsuya,Yoshino Takayuki,Yana Ikuo,Ueno Hiroshi,Ohtsu Atsushi

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/44/3/214/11686275/hyt196.pdf

Reference33 articles.

1. Cancer treatment and survivorship statistics, 2012;Siegel;CA Cancer J Clin,2012

2. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

3. International trends in colorectal cancer incidence rates;Center;Cancer Epidemiol Biomarkers Prev,2009

4. Panitumumab in colorectal cancer;Wainberg;Expert Rev Anticancer Ther,2007

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of infusion-related reactions in cancer therapy: strategies and challenges;ESMO Open;2024-03

2. Anti-EGFR Antibodies (Cetuximab, Panitumumab, and Necitumumab);Analysis File of Drug-Induced Lung Injury;2024

3. Adverse Renal Effects of Anticancer Immunotherapy: A Review;Cancers;2022-08-23

4. Cardiovascular Risks with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors and Monoclonal Antibody Therapy;Current Oncology Reports;2022-02-22

5. Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal Cancer;Clinical Colorectal Cancer;2021-12